C9H15BN2O2
194.04 g/mol
의약 중간체경고
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS269410-08-4EC629-131-7
용도 분류
의약 중간체
화합물 분류
헤테로사이클
주요 용도
의약 중간체
This compound is a boronic ester derivative featuring a pyrazole ring, used as a research reagent and pharmaceutical intermediate. Its primary significance lies in its role as a building block for borylation reactions in organic synthesis.
Pharmaceutical intermediate for borylation reactionsBuilding block in medicinal chemistry research
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 269410-08-4
관련 화합물
용도 관련동일 용도
2,2,6,6-TETRAMETHYL-3,6-DIHYDRO-2H-PYRAN-4-BORONIC ACID PINACOL ESTER
CAS1142363-56-1
Pharmaceutical intermediate for borylation reactions
참고동일 카테고리
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol
CAS269410-21-1
Pharmaceutical intermediate for API synthesis
참고동일 카테고리
DBCO-PEG4-GGFG-Exatecan (Repodatecan starting material)
CAS2694856-51-2
antibody-drug conjugate linker payload intermediate
참고동일 카테고리
8-Bromo-1-octene
CAS2695-48-9
Pharmaceutical intermediate
참고동일 카테고리
3-Deoxy-3-acetylabiraterone-3-ene
CAS2697127-16-3
Abiraterone acetate impurity intermediate
참고same scaffold
Tert-butyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate
CAS552846-17-0
pharmaceutical intermediate
참고same scaffold
1-Propyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS827614-69-7
Boronic ester for chemical synthesis
참고same scaffold
1,3,5-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS844891-04-9
Boronic ester synthetic intermediate
안전 참조
경고
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
식별자
IUPAC 이름
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
InChIKey
TVOJIBGZFYMWDT-UHFFFAOYSA-N
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CNN=C2
동의어 목록 (16)
- Baricitinib Impurity 32